Genomic Main Phase - Early Diagnosis

Lead Participant: GLAXOSMITHKLINE PLC

Abstract

Awaiting Public Project Summary

Lead Participant

Project Cost

Grant Offer

GLAXOSMITHKLINE PLC £12,500,000 £ 12,500,000
 

Participant

INNOVATE UK

Publications

10 25 50